Leap Investments’s Genmab GMAB Stock Holding History

Leap Investments’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$576K	Buy	17,000 +5,400	+47%	+$147K	0.38%	86
2020 Q1	$246K	Buy	+11,600	New	+$259K	0.36%	112

Other funds holding GMAB

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Leap Investments's GMAB Position: Q2 2020 in Review

Leap Investments increased its Genmab (GMAB) stake by 47% in Q2 2020, buying an estimated $147K and bringing the position to 17,000 shares worth $576K. The position accounts for 0.38% of the portfolio, ranked #86.

Leap Investments first reported a position in GMAB in Q1 2020 and has held it in 2 quarters since. 174 funds tracked by Wall St. Rank hold GMAB as of Q2 2020.

Leap Investments held 17,000 shares of Genmab worth $576K as of Q2 2020.
Leap Investments bought 5,400 Genmab shares in Q2 2020, an estimated $147K.
Genmab made up 0.38% of Leap Investments's portfolio in Q2 2020, its #86 holding.
Leap Investments first reported a position in Genmab in Q1 2020 and has held it in 2 quarters since.
174 funds tracked by Wall St. Rank held Genmab as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.